Gastrointestinal Cancer News

Edith Peterson Mitchell, MD, has been chosen as this year’s American Society for Radiation Oncology honorary member.

Researchers from the University of Arizona Steele Children’s Research Center will study how NHE8, a protein that absorbs sodium in the gut, contributes to the development of inflammatory bowel disease, colon cancer and the stability of the gut microbiome, according to a press release.

The FDA took action this week on several treatments intended to benefit patients with cancer.

Patients who achieved sustained virologic response after direct-acting antiviral treatment also had significantly lower all-cause mortality and lower incident rates of hepatocellular carcinoma compared with patients who did not achieve SVR.

The addition of stereotactic body radiotherapy to chemotherapy extended OS among patients with unresectable pancreatic cancer, according to data from a retrospective analysis.

Mutated gene and mutation type can dictate at which age patients with Lynch syndrome should begin cancer surveillance, according to results of a retrospective cohort study.

Patients with advanced cancer who arrived at the ED with delirium had increased rates of hospitalization and ICU admissions, as well as shorter survival rates, according to a study published in The Oncologist.

Patients with advanced cancer had significantly lower survival rates following in-hospital cardiac arrest than those without advanced cancer, according to a retrospective study published in Journal of Oncology Practice.

The FDA approved nivolumab for the treatment of adult and pediatric patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin and irinotecan, according to the drug’s manufacturer.

A history of periodontal disease increased risk for total cancer among postmenopausal women, regardless of smoking status, according to results of a prospective cohort study.